Impetigo in epidemic and nonepidemic phases: An incidence study over 4 1/2 years in a general population

British Journal of Dermatology

Volumn 157, Issue 1, 2007, Pages 100-105

  Rortveit S ^a   Rortveit, G ^b,c  

^a Municipal Health Services of Austevoll Kommune   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c Research Unit for General Practice   (Norway)

Author keywords

Epidemic; Fusidic acid; Impetigo; Population based; Skin diseases; Staphylococcal infections

Indexed keywords

ERYTHROMYCIN; FUSIDIC ACID; PENICILLIN G;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE COURSE; EPIDEMIC; HEALTH SURVEY; HUMAN; IMPETIGO; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NORWAY; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; FUSIDIC ACID; HUMANS; IMPETIGO; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NORWAY;

EID: 34250654447     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07969.x     Document Type: Article

References (16)

1. Koning S, van der Wouden JC. Treatment for impetigo. BMJ 2004 329 : 695 6.
2. Koning S, Mohammedamin RS, van der Wouden JC et al. Impetigo: incidence and treatment in Dutch general practice in 1987 and 2001 - results from two national surveys. Br J Dermatol 2006 154 : 239 43.
3. Elliot AJ, Cross KW, Smith GE et al. The association between impetigo, insect bites and air temperature: a retrospective 5-year study (1999-2003) using morbidity data collected from a sentinel general practice network database. Fam Pract 2006 23 : 490 6.
4. Rogers M, Dorman D, Gapes M, Ly J. A three-year study of impetigo in Sydney. Med J Aust 1987 147 : 63 5.
5. Loffeld A, Davies P, Lewis A, Moss C. Seasonal occurrence of impetigo: a retrospective 8-year review (1996-2003). Clin Exp Dermatol 2005 30 : 512 14.
6. Koning S, van Suijlekom-Smit LW, Nouwen JL et al. Fusidic acid cream in the treatment of impetigo in general practice: double blind randomised placebo controlled trial. BMJ 2002 324 : 203 6.
7. Tveten Y, Jenkins A, Kristiansen BE. A fusidic acid-resistant clone of Staphylococcus aureus associated with impetigo bullosa is spreading in Norway. J Antimicrob Chemother 2002 50 : 873 6.
8. Österlund A, Eden T, Olsson-Liljequist B et al. Clonal spread among Swedish children of a Staphylococcus aureus strain resistant to fusidic acid. Scand J Infect Dis 2002 34 : 729 34.
9. Ravenscroft JC, Layton A, Barnham M. Observations on high levels of fusidic acid resistant Staphylococcus aureus in Harrogate, North Yorkshire, UK. Clin Exp Dermatol 2000 25 : 327 30.
10. Österlund A, Kahlmeter G, Haeggman S, Olsson-Liljequist B. Staphylococcus aureus resistant to fusidic acid among Swedish children: a follow-up study. Scand J Infect Dis 2006 38 : 332 4.
11. Statens Legemiddelverk. Terapianbefalinger ved impetigo (brennkopper). MSIS-Rapport 2003 31 : 1B.
12. Rørtveit S, Rortveit G. An epidemic of bullous impetigo in the municipality of Austevoll in the year 2002. Tidsskr Nor Laegeforen 2003 123 : 2557 60.
13. Statistics Norway. Population Numbers, 1 January 2005. Available at: http://www.ssb.no/emner/03/hjulet/tabell-01.html (last accessed 16 May 2007).
14. Carey R. Improving Healthcare with Control Charts: Basic and Advanced SPC Methods and Case Studies. Milwaukee : ASQ Quality Press, 2003.
15. Arantes A, Carvalho Eda S, Medeiros EA et al. Use of statistical process control charts in the epidemiological surveillance of nosocomial infections. Rev Saude Publica 2003 37 : 768 74.
16. Naumova EN, O'Neil E, MacNeill I. INFERNO: a system for early outbreak detection and signature forecasting. MMWR Morb Mortal Wkly Rep 2005 54 (Suppl. 77 83.